ToxPredictor accurately predicts drug induced liver injury (DILI) to offer a valuable “go/no-go” tool in clinical decision making.

The leaders of two Native American reservations in southern Colorado recently called the state's ban on their ability to ...

In an insightful discussion at Fyuz 2025 in Dublin, Ray Dolan, CEO of Cohere Technologies, shares updates on his company’s ...

Johnson & Johnson's planned $3 billion acquisition of Halda Therapeutics is one of the largest deals for a CT-based biotech ...

The world-renowned, peer-reviewed, open-access Nature journal, Signal Transduction and Targeted Therapy, publishes original ...

Guest blog by Richard Jacklin, Commercial Lead for Space at Plextek, and James Snape, Founder of Aphelion Industries ...

Complex, chronic wounds are increasingly recognized as life-altering conditions with mortality rates rivaling or surpassing certain cancers. A new publication from JWC entitled "Application of a ...

PM Eastern Time, today. LOS ANGELES, CALIFORNIA / ACCESS Newswire / November 13, 2025 / Today, eXoZymes Inc. ("eXoZymes") - a pioneer of AI-enhanced enzymes that can transform sustainable ...

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: ...

By 2017, there were more than ten cars fitted with this technology for the 2018 model year, including the Range Rover, BMW ...

J&J will acquire Halda Therapeutics in a $3.05B deal, adding prostate cancer therapy HLD-0915 and expanding its oncology ...